Robust Bayesian methods for monitoring clinical trials.

Bayesian methods for the analysis of clinical trials data have received increasing attention recently as they offer an approach for dealing with difficult problems that arise in practice. A major criticism of the Bayesian approach, however, has focused on the need to specify a single, often subjective, prior distribution for the parameters of interest. In an attempt to address this criticism, we describe methods for assessing the robustness of the posterior distribution to the specification of the prior. The robust Bayesian approach to data analysis replaces the prior distribution with a class of prior distributions and investigates how the inferences might change as the prior varies over this class. The purpose of this paper is to illustrate the application of robust Bayesian methods to the analysis of clinical trials data. Using two examples of clinical trials taken from the literature, we illustrate how to use these methods to help a data monitoring committee decide whether or not to stop a trial early.

[1]  W. Wong,et al.  The calculation of posterior distributions by data augmentation , 1987 .

[2]  J. Berger,et al.  Ranges of posterior measures for priors with unimodal contaminations , 1989 .

[3]  D. Spiegelhalter,et al.  The Assessment of the Subjective Opinion and its Use in Relation to Stopping Rules for Clinical Trials , 1983 .

[4]  Siva Sivaganesan,et al.  Range of posterior measures for priors with arbitrary contaminations , 1988 .

[5]  L. M. Berliner,et al.  Robust Bayes and Empirical Bayes Analysis with $_\epsilon$-Contaminated Priors , 1986 .

[6]  L L Miller,et al.  Stopping a clinical trial very early because of toxicity: summarizing the evidence. , 1993, Controlled clinical trials.

[7]  L. Tierney Exploring Posterior Distributions Using Markov Chains , 1992 .

[8]  D J Spiegelhalter,et al.  Comparison of Bayesian with group sequential methods for monitoring clinical trials. , 1989, Controlled clinical trials.

[9]  J Cornfield,et al.  The Bayesian outlook and its application. , 1969, Biometrics.

[10]  S. Emerson,et al.  Stopping a clinical trial very early based on unplanned interim analyses: a group sequential approach. , 1995, Biometrics.

[11]  M D Hughes,et al.  Reporting Bayesian analyses of clinical trials. , 1993, Statistics in medicine.

[12]  J. Berger Robust Bayesian analysis : sensitivity to the prior , 1990 .

[13]  D. Berry Monitoring accumulating data in a clinical trial. , 1989, Biometrics.

[14]  L. Wasserman,et al.  Bayesian Inference with Specified Prior Marginals , 1991 .

[15]  Ward Edwards,et al.  Bayesian statistical inference for psychological research. , 1963 .

[16]  Thomas A. Louis,et al.  Graphical Elicitation of a Prior Distribution for a Clinical Trial , 1993 .

[17]  Adrian F. M. Smith,et al.  Sampling-Based Approaches to Calculating Marginal Densities , 1990 .

[18]  J B Kadane,et al.  Progress toward a more ethical method for clinical trials. , 1986, The Journal of medicine and philosophy.